Horizon Therapeutics USA, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Horizon Therapeutics USA, Inc.
Quantité totale PI 56
Rang # Quantité totale PI 24 988
Note d'activité PI 2,2/5.0    21
Rang # Activité PI 38 487
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

38 10
1 5
0 1
1
 
Dernier brevet 2025 - Methods and kits for predicting ...
Premier brevet 1999 - Peg-urate oxidase conjugates and...
Dernière marque 2020 - GOUT REVEALED
Première marque 2008 - DUEXIS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Methods and kits for predicting infusion reaction risk and antibody mediated loss of response by ...
Invention Tolerization reduces intolerance to pegloticase and prolongs the urate lowering effect (triple). ...
Invention Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by ...
2023 Invention Reducing immunogenicity to pegloticase. The disclosure provides methods of treating gout in pati...
Invention Purification of proteins with cationic surfactant. The subject invention provides a method for p...
2022 Invention Reducing immunogenicity to pegloticase. The disclosure provides methods of treating gout in patie...
Invention Variant forms of urate oxidase and use thereof. Genetically modified proteins with uricolytic act...
2021 Invention Methods of treating gout. The disclosure provides methods of treating gout in patients comprisin...
2020 P/S Medical services, namely, providing Internet-based medical information for patients on medical is...
P/S Providing a website featuring information relating to inflammatory, metabolic and rheumatological...
Invention Methods for treating gout. The disclosure provides methods of treating gout in patients comprisin...
2017 Invention Combination therapies of prednisone and uricase molecules and uses thereof. Described herein are...
P/S Pharmaceutical preparations for the treatment of rheumatological conditions; pharmaceutical prepa...
Invention Variant forms of urate oxidase and use thereof. Genetically modified proteins with uricolytic ac...
P/S Brochures, newsletters, and pamphlets relating to medical issues, procedures, disease symptoms an...
P/S Brochures, newsletters, and pamphlets relating to medical issues, procedures, disease symptoms a...
P/S medical services, namely, providing internet-based medical information for patients on medical is...
2016 P/S Pharmaceutical preparations for the treatment of elevated levels of uric acid in the body and/or ...
2015 Invention Peg-urate oxidase conjugates and use thereof. A naturally occurring or recombinant urate oxidase ...
P/S Scientific and medical research relating to inflammatory, gastroenterological, metabolic, auto-im...
2014 Invention Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates. A naturally ...
2012 Invention Variant form of urate oxidase and use thereof. The present invention relates to genetically modif...
P/S Pharmaceutical preparations for the treatment of rheumatoid diseases and other inflammatory disor...
2011 Invention Peg-urate oxidase conjugates and use thereof. A naturally occurring or recombinant urate oxidase...
Invention Method for purifying urate oxidase tetramers and octamers. A naturally occurring or recombinant p...
2010 P/S pharmaceutical preparations for the treatment of osteoarthritis, asthma, rheumatoid diseases, and...
Invention Method for treating a patient at risk for developing an nsaid-associated ulcer. The present discl...
P/S Pharmaceutical preparations and substances for the treatment of pain, inflammation and gastrointe...
2009 Invention Method for delivering a pharmaceutical composition to patient in need thereof. The present disclo...
2008 P/S pharmaceutical preparations and substances for the treatment of pain, inflammation and gastrointe...
2006 Invention Purification of proteins with cationic surfactant. The subject invention provides a method for pu...